Resorbable (Bioresorbable) Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The Resorbable (Bioresorbable) Polymers Market was valued at USD 460.80 Million in 2024, and is expected to reach USD 615.43 Million by 2030, rising at a CAGR of 4.90%. Bioresorbable polymers, a groundbreaking technological advancement in the field of materials, offer a unique characteristic of being broken down by the body without requiring mechanical removal, such as sutures or the chlorhexidine chip. These bioresorbable materials find applications in a wide range of medical indications, including sutures, coronary and peripheral vascular scaffolds, tissue fixation screws, bone pins and anchors, drug delivery coatings, as well as microspheres, surgical meshes, and matrices.

The materials in this category encompass polymers, metals, ceramics, glasses, and even materials of biological origin like natural collagen, which not only allow for drug elution and delivery but also serve mechanical functions. Currently, the bioresorbable market is in its developing stage, although bioresorbable sutures have been available for over 40 years. Recent innovations have expanded the market to encompass cardiovascular, orthopedic, and general surgery.

Looking ahead, the global bioresorbable market is anticipated to witness substantial growth, driven by the increasing demand from major applications such as orthopedics and drug delivery. Factors contributing to the growth of the bioresorbable market include patient-friendliness, the rising demand for drugs and medicines, the growing number of surgeries, and the increasing awareness among people. However, it is important to note that technological sophistication resulting in higher costs may pose a challenge and restrain the growth of the market.

Key Market Drivers

Rising Demand for Biodegradable and Biocompatible Materials in Healthcare

The increasing demand for biodegradable and biocompatible materials in healthcare is a primary factor driving the growth of the global resorbable (bioresorbable) polymers market. As the medical industry shifts towards patient-centric, minimally invasive, and sustainable solutions, bioresorbable polymers are emerging as an essential material class due to their ability to degrade naturally in the body without requiring surgical removal. Traditional medical implants made from metals or permanent synthetic polymers often require secondary surgeries for removal, which increases patient risk, healthcare costs, and recovery time.

In contrast, bioresorbable polymers naturally degrade within the body after fulfilling their intended function, eliminating the need for additional procedures. Orthopedic implants, where bioresorbable screws, pins, and plates provide temporary structural support and gradually dissolve as bones heal. Osteoarthritis predominantly impacts individuals aged 55 and older, who account for 73% of cases, with women representing 60% of those affected (1). The condition most commonly affects the knee, with 365 million cases globally, followed by the hip and hand (2). Of these, 344 million people experience moderate to severe symptoms, indicating a significant population that could benefit from targeted rehabilitation interventions.

These figures underscore the growing need for effective solutions to address the burden of osteoarthritis, particularly in aging demographics. Cardiovascular stents, which reduce long-term complications by dissolving once arteries regain functionality. In 2022, the global prevalence of coronary artery disease (CAD) was estimated at 315 million cases, with a 95% uncertainty range of 273 million to 362 million. The age-standardized prevalence rate stood at 3,605 cases per 100,000 people (uncertainty interval: 2,892 to 4,454 per 100,000), reflecting an 18% decline from 1990, when the rate was 4,390 per 100,000 (uncertainty interval: 3,510 to 5,445 per 100,000). Regional disparities were significant.

Central Europe, Eastern Europe, and Central Asia recorded the highest age-standardized prevalence in 2022, reaching 8,019 cases per 100,000 (uncertainty interval: 6,530 to 9,719 per 100,000). In contrast, South Asia reported the lowest prevalence, at 2,393 cases per 100,000 (uncertainty interval: 1,746 to 3,188 per 100,000). Soft tissue regeneration, where bioresorbable scaffolds promote cell growth and eventually disappear as new tissue forms. The growing preference for temporary, biodegradable implants is a major driver of market growth, as healthcare providers and patients seek safer, more efficient treatment options.

Bioresorbable sutures and meshes are becoming standard in wound closure and surgical applications due to their ability to: Minimize infection risks, as they dissolve naturally and do not require removal. Enhance healing, as they degrade at a controlled rate, reducing tissue damage. Improve patient comfort, eliminating the discomfort of suture removal. The increasing volume of surgeries worldwide - driven by aging populations, chronic diseases, and trauma cases - is further propelling demand for bioabsorbable wound closure products. Pharmaceutical companies are increasingly utilizing bioresorbable polymers in controlled and targeted drug delivery systems.

These materials offer several advantages: Sustained drug release, ensuring consistent medication levels over time. Reduced side effects, as localized delivery minimizes systemic exposure. Personalized treatment options, with customizable degradation rates for specific medical needs. Implantable drug delivery systems for chemotherapy, which release drugs at a controlled pace and dissolve after treatment. Microspheres and nanoparticles for long-acting injectable medications in cancer and chronic disease management. Bioresorbable coatings on medical devices, enhancing their therapeutic effectiveness. The push towards precision medicine and advanced drug delivery technologies is significantly boosting demand for bioresorbable polymers.

Key Market Challenges

Complexities Associated with Biocompatibility and Safety

Bioresorbable polymers are highly regarded for their exceptional biocompatibility, which enables them to be safely absorbed by the body once their purpose is fulfilled. This outstanding quality makes them ideal for a wide range of applications in the medical field, including medical devices and drug delivery systems, as well as various biomedical applications.

However, achieving the desired level of biocompatibility is a complex and intricate process. While synthetic polymers can help avoid issues with immunogenicity, they can introduce new challenges in ensuring biocompatibility. Thus, the development of bioresorbable polymers requires a delicate balance to ensure that these materials interact with the body without causing any adverse reactions.

In addition to biocompatibility, safety is another crucial aspect when it comes to bioresorbable polymers. Scientific evaluations have indicated that these polymers are generally safe for use in medical devices. However, their safety profile primarily depends on their design and how they degrade within the body. It is crucial that the degradation process of bioresorbable polymers is both predictable and safe, without causing any harm to the body. This necessitates rigorous testing and stringent quality control measures, adding yet another layer of complexity to the development and production of these materials.

Undoubtedly, the complexities associated with biocompatibility and safety pose significant challenges for the resorbable polymers market. These challenges can impede product development, elevate costs, and create barriers to market entry. Nonetheless, these complexities also serve as drivers for innovation within the market. They compel companies to invest in extensive research and development efforts, leading to the creation of advanced bioresorbable polymers with improved biocompatibility and enhanced safety profiles. By addressing these challenges head-on, the industry can pave the way for groundbreaking advancements in the field of bioresorbable polymers.

Key Market Trends

Growing Focus on Tissue Engineering

Tissue engineering, a highly interdisciplinary field, aims to develop functional tissues to restore, maintain, or enhance damaged tissues or whole organs. It involves the use of resorbable polymers as scaffolds, providing a three-dimensional structure for the growth of new tissue. These polymers, known for their biocompatibility and ability to safely degrade within the body, are ideal for tissue engineering applications.

The rising focus on regenerative medicine and tissue engineering is driving the demand for resorbable polymers. This growing trend has significant implications for the resorbable polymers market. Firstly, it leads to an increased demand for these materials, contributing to market growth. The application of resorbable polymers in tissue engineering is expected to continue expanding, further fueling the demand.

Moreover, this trend also spurs innovation in the market. With the increasing use of polymers in tissue engineering, companies are motivated to develop advanced bioresorbable polymers with improved properties, such as enhanced strength and flexibility. This drive for innovation pushes the boundaries of what is possible in tissue engineering.

Furthermore, the emphasis on tissue engineering encourages extensive research and development efforts in the field of resorbable polymers. This results in ongoing product developments and a significant increase in investment in research and development activities. Scientists and engineers strive to optimize the properties and performance of resorbable polymers, paving the way for breakthroughs in tissue engineering applications.

In conclusion, the growing focus on tissue engineering represents a significant and transformative trend in the global resorbable polymers market. As the field of tissue engineering continues to evolve and expand, the role of resorbable polymers in this field is set to become increasingly important, positively impacting the market's growth. The continuous advancements in resorbable polymers hold tremendous potential for revolutionizing regenerative medicine and improving patients' lives.

Key Market Players

• Corbion NV
• Poly-Med, Inc.
• Foster Corporation
• Evonik Industries AG
• KLS-Martin Limited
• 3d Biotek LLC
• Degradable solutions AG
• Koninklijke DSM N.V.
• FUTERRO S.A.
• Abbott Laboratories Inc

Report Scope:

In this report, the Global Resorbable (Bioresorbable) Polymers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Resorbable (Bioresorbable) Polymers Market, By Type:

• Agro-Polymers
• Biopolyesters
• Others

Resorbable (Bioresorbable) Polymers Market, By Application:

• Orthopedics
• Cardiac Implants
• Dental Implants
• Oral Drug Delivery
• Others

Resorbable (Bioresorbable) Polymers Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Resorbable (Bioresorbable) Polymers Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.